[{"NetIncomeLoss_1_Q2_USD":-29955000.0,"InterestIncomeOther_1_Q2_USD":210000.0,"RestrictedCashCurrent_0_Q2_USD":383000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q2_USD":8.17,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-41000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":94783000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_2_Q2_pure":0.0117,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-134809000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":770976.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":52000.0,"AssetsCurrent_0_Q2_USD":461297000.0,"OperatingLeaseExpense_2_Q2_USD":400000.0,"OperatingLeaseExpense_1_Q2_USD":200000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":7918682.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":25000.0,"CommonStockSharesIssued_0_Q2_shares":51441908.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":177204000.0,"Assets_0_Q2_USD":467147000.0,"ShareBasedCompensation_2_Q2_USD":7891000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":376000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":11.78,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":3000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":21393000.0,"CommonStockSharesAuthorized_0_Q2_shares":200000000.0,"InterestIncomeOther_2_Q2_USD":375000.0,"OperatingIncomeLoss_2_Q2_USD":-55298000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":51216254.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":578000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":42496000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":23872000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":8.2,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":406000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":375000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":210000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2_Q2_pure":0.74,"CommonStockValue_0_Q2_USD":6000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":487000.0,"DepreciationDepletionAndAmortization_1_Q2_USD":200000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":157275000.0,"IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_2_Q2_USD":2842000.0,"RestrictedCash_0_Q2_USD":2700000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q2_USD":8499000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-54937000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-29928000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":258385000.0,"Liabilities_0_Q2_USD":14551000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":-14000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":27000.0,"OperatingLeaseLiability_0_Q2_USD":403000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":5.59,"GeneralAndAdministrativeExpense_2_Q2_USD":12802000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":6293000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":50349193.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":406000.0,"OperatingIncomeLoss_1_Q2_USD":-30165000.0,"ProceedsFromIssuanceInitialPublicOffering_2_Q2_USD":157237000.0,"RestrictedCashNoncurrent_0_Q2_USD":2308000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":156562000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q2_shares":6767389.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":1483000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":11000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":4239000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-64543000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q2_USD":140960000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_0_Q2_USD":87112000.0,"AccountsPayableCurrent_0_Q2_USD":5649000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":261076000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":25708000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":38000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.0325,"AreaOfLand_0_Q2_sqft":68187.0,"AdditionalPaidInCapital_0_Q2_USD":586737000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":261076000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_2_Q2_pure":0.0088,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":21251.0,"NumberOfOperatingSegments_2_Q2_Segment":1.0,"OperatingLeasePayments_2_Q2_USD":394000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":383000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":18804000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":2589000.0,"NetIncomeLoss_2_Q2_USD":-54923000.0,"CommonStockSharesOutstanding_0_Q2_shares":51232341.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":177204000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-42077000.0,"LeaseCost_2_Q2_USD":625000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":18.3,"PreferredStockValue_0_Q2_USD":null,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":1.23,"OperatingLeaseCost_2_Q2_USD":379000.0,"OperatingLeaseCost_1_Q2_USD":189000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":467147000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":1591000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":7891000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":4239000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":10664.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":4072000.0,"OperatingExpenses_2_Q2_USD":55298000.0,"OperatingExpenses_1_Q2_USD":30165000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.58,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.09,"ProfitLoss_2_Q2_USD":-54923000.0,"StockholdersEquity_0_Q2_USD":452596000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":747000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":177245000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":7160650.0,"VariableLeaseCost_2_Q2_USD":246000.0,"VariableLeaseCost_1_Q2_USD":131000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":1186660.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-134106000.0,"LeaseCost_1_Q2_USD":320000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":203000.0,"Ticker":"DYN","CIK":"1818794","name":"DYNE THERAPEUTICS, INC.","OfficialName":"Dyne Therapeutics Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"463184796.0","Country":"United States","Sector":"Consumer Durables","Industry":"Specialty Chemicals","Market":"NASDAQ","SP500":"nan","filed":"20210805"}]